News

BBC News talked to Dr. Mikhail Kosiborod about new findings on the cardiovascular effects of semaglutide.

A new subanalysis presented by Dr. Mikhail Kosiborod shows benefits of semaglutide in patients with atrial fibrillation.

Nearly 7 million people in the U.S. are living with Alzheimer’s disease. That number is expected to double by the year 2060.

Lynn vividly remembers how she felt when she found out she had stage 2 breast cancer at age 44, shortly after cancer claimed her sister’s life.